CA Patent

CA2751761A1 — Treatment and/or prevention of inner ear conditions by modulation of a metabotropic glutamate receptor

Assigned to House Ear Institute · Expires 2010-04-29 · 16y expired

What this patent protects

Described herein are com-positions and methods of treating and/or preventing inner ear conditions by admin-istering to a patient in need thereof a mod-ulator of a metabotropic glutamate recep-tor.

USPTO Abstract

Described herein are com-positions and methods of treating and/or preventing inner ear conditions by admin-istering to a patient in need thereof a mod-ulator of a metabotropic glutamate recep-tor.

Drugs covered by this patent

Patent Metadata

Patent number
CA2751761A1
Jurisdiction
CA
Classification
—
Expires
2010-04-29
Drug substance claim
No
Drug product claim
No
Assignee
House Ear Institute
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.